Söndag 22 December | 03:45:08 Europe / Stockholm

Kalender

Tid*
2024-08-29 - Kvartalsrapport 2024-Q2
2024-05-16 - X-dag ordinarie utdelning BRAINP 0.00 DKK
2024-05-15 - Årsstämma
2024-05-07 - Bokslutskommuniké 2023
2023-10-11 - Extra Bolagsstämma 2023
2023-08-31 - Kvartalsrapport 2023-Q2
2023-05-30 - X-dag ordinarie utdelning BRAINP 0.00 DKK
2023-05-26 - Årsstämma
2023-04-28 - Bokslutskommuniké 2022
2022-09-29 - Kvartalsrapport 2022-Q2
2022-09-02 - Extra Bolagsstämma 2022
2022-05-19 - X-dag ordinarie utdelning BRAINP 0.00 DKK
2022-05-18 - Årsstämma
2022-04-29 - Bokslutskommuniké 2021

Beskrivning

LandDanmark
ListaFirst North Denmark
SektorHälsovård
IndustriVård & Omsorg
Brain+ är verksamt inom läkemedelsbranschen. Bolaget är specialiserat inom forskning och utveckling för behandling av demens och alzheimers. Produktportföljen inkluderar exempelvis kognitiv stimuleringsterapi. Utöver huvudverksamheten erbjuds även service och tillhörande kringtjänster. Verksamheten drivs med störst närvaro inom Europa. Brain+ har sitt huvudkontor i Köpenhamn.
2024-06-24 10:06:20
Copenhagen, Denmark, 24 June 2024 – Brain+ A/S (Nasdaq First North: BRAINP) Brain+ A/S (“Brain+” or the “Company”) announces that the Company has agreed to expand the top-down guarantee tranche in the ongoing rights issue of units of approximately DKK 8.94 million (the “Rights Issue”) with additional DKK 200,000. The top-down guarantee is to the same terms as members from the board and management of Brain+ have agreed to. In total, top-down guarantees now amount to DKK 928,822 and the Rights Issue is covered 66.6% by pre-subscription and guarantee commitments, corresponding to approximately DKK 6.0 million in pre-secured gross proceeds to Brain+.


Additional top-down guarantee
Naapster ApS has agreed with Brain+ to enter into a top-down guarantee agreeement of DKK 200,000. Including this additional commitment, the total top-down guarantee tranche amounts to DKK 928,822 or 10.4% of the Rights Issue. Investors in the top-down guarantee have agreed to subscribe for units to the extent that the Rights Issue is not subscribed to 100%, however no more than their individual guarantee amount. For guarantors in the top-down tranche, a compensation of 10% of their commitment will be payable in the form of units, issued to the same terms as in the Rights Issue.

The rights issue, pre-commitments and guarantee commitments
The subscription period in the Rights Issue of units ends today, Monday 24 June 2024. Investors are advised to subscribe through their respective custodian bank or through Nordic Issuing AB. In its corporate announcement from 20 June 2024, Brain+ informed that the Rights Issue was secured to 64.4% through subscription and guarantee commitments. With the additional to-down commitment from Naapster ApS, the Rights Issue is now secured to 66.6 percent.

For complete information of the Rights Issue please see the company announcements from 7 and 22 May 2024, which can be found on Brain+ website under this link: Company releases & financial documents - Brain+ Better brain better life (brain-plus.com)

Questions related to the Rights Issue
In case of any question about Brain+, the Rights Issue or the financial instruments, you are welcome to reach out to either Brain+ CEO Kim Baden-Kristensen, Brain+ CFO Hanne Vissing Leth, Brain+ financial adviser Sedermera Corporate Finance or the issuing agent Nordic Issuing using the contact details at the bottom of this company announcement.

Advisors
In connection with the Rights Issue, Sedermera Corporate Finance AB act as financial advisors to Brain+. Markets & Corporate Law Nordic AB act as legal advisor. Nordic Issuing AB it the issuing agent and the settlement agent.

For more information about the Rights Issue, please contact:
Sedermera Corporate Finance AB
Phone: +46 (0) 40 615 14 10

E-mail: cf@sedermera.se
www.sedermera.se

For more information about technicalities and the financial instruments, please contact:
Nordic Issuing AB
Phone: +46 (0) 40 632 00 20

E-mail: info@nordic-issuing.se

www.nordic-issuing.se
 

For more information about Brain+, please contact:
Kim Baden-Kristensen, CEO
Phone: +45 31 39 33 17
E-mail: 
kim@brain-plus.com

Or,

Hanne Vissing Leth, CFO
Phone: +45 53 88 99 02
E-mail: hanne@brain-plus.com

www.brain-plus.com

Certified Adviser
Keswick Global AG
Phone: +43 1 740 408 045
E-mail: info@keswickglobal.com